Parlux
This article was originally published in The Rose Sheet
Executive Summary
Revenues for the fiscal year ended March 31, 2005 are expected to increase 26% to approximately $100 mil., the Fort Lauderdale, Fla. firm reports May 2. Earnings per share are projected to be up around 60% to $.99-$1.01, Parlux says. Results were boosted by the strength of the Perry Ellis fragrance brand, as well as the Paris Hilton range, firm notes. The international rollout of Paris Hilton has been "extremely successful," and is "paving the road for the Guess launch," which is slated for this year (1"The Rose Sheet" Nov. 10, 2003, p. 4). Final results for Q4 and the full fiscal year will be announced in June...
You may also be interested in...
Guess? Fragrances Will Be Reintroduced By Parlux In 2005
Fragrance marketer Parlux will launch Guess? scents in over 1,000 U.S. specialty store doors and all freestanding Guess boutiques in early 2005, Parlux VP Marketing Kathleen Galvin said
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.